A Crucial Group of Covid Drugs Has Stopped Working

The changing nature of the virus also makes it difficult to conduct human clinical trials and get a new antibody to patients in time for it to work against the current variants. At a meeting in December, drugmakers asked US and European regulators to consider adopting new standards for approving new antibody drugs, especially those meant for immunocompromised people. They suggested that new antibody drugs that are similar to previously authorized ones shouldn’t have to go through large clinical trials to test their effectiveness. Instead, extensive lab tests and small safety trials, like what’s done for the annual flu vaccine, may be sufficient.  

Researchers are now looking for the holy grail

→ Continue reading at Wired - Science

More from author

Related posts

Advertisment

Latest posts

Save Time by Leveraging This AI Content Generation Tool for $20

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may...

GM pauses sales of Chevy Blazer EV over software issues | CNN Business

New York CNN  —  GM has paused sales of its brand new Chevy Blazer EVs after some customers reported...

Get This AI Photo Editing Bundle for Only $150 Through December 25th

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may...